NWSA vs NXL · rev $9.03B vs rev $301.6K
NWSA (NWSA) versus Nexalin Technology Inc. (NXL) — a side-by-side from cached financials, not a winner call.
NWSA (NWSA) common stock.
Nexalin Technology Inc. (NXL) is a medical devices company listed on NASDAQ.
Latest reported NWSA revenue for 2026-06-30 was $9.03B. Net income was $573.0M. Revenue was up 328.1% from 2025-06-30 to 2026-06-30. NWSA currently screens at market cap $0.
Latest reported NXL revenue for 2025-12-31 was $301.6K. Net income was -$8.2M. Revenue was up 78.8% from 2024-12-31 to 2025-12-31. NXL currently screens at market cap $8.5M.
NWSA currently screens at market cap $0. NXL currently screens at market cap $8.5M.
Not investment advice. Open the NWSA and NXL stock pages for the full models.
Not investment advice.